Analysts Are Bullish on These Healthcare Stocks: Cigna (CI), Lexicon Pharmaceuticals (LXRX)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cigna (CI – Research Report), Lexicon Pharmaceuticals (LXRX – Research Report) and Irhythm Technologies (IRTC – Research Report) with bullish sentiments.

Cigna (CI)

In a report released today, Michael Wiederhorn from Oppenheimer maintained a Buy rating on Cigna, with a price target of $400.00. The company’s shares closed last Thursday at $344.50.

According to TipRanks.com, Wiederhorn is a top 100 analyst with an average return of 15.3% and a 67.3% success rate. Wiederhorn covers the Healthcare sector, focusing on stocks such as Cross Country Healthcare, Community Health, and The Ensign Group.

Cigna has an analyst consensus of Strong Buy, with a price target consensus of $393.07, representing a 9.2% upside. In a report released today, Cantor Fitzgerald also maintained a Buy rating on the stock with a $400.00 price target.

See the top stocks recommended by analysts >>

Lexicon Pharmaceuticals (LXRX)

In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Lexicon Pharmaceuticals, with a price target of $10.00. The company’s shares closed last Thursday at $1.70.

According to TipRanks.com, Rahimi is a 4-star analyst with an average return of 4.2% and a 36.6% success rate. Rahimi covers the Healthcare sector, focusing on stocks such as Structure Therapeutics, Inc. Sponsored ADR, Praxis Precision Medicines, and Crinetics Pharmaceuticals.

Currently, the analyst consensus on Lexicon Pharmaceuticals is a Strong Buy with an average price target of $6.33, implying a 265.9% upside from current levels. In a report issued on April 30, Leerink Partners also initiated coverage with a Buy rating on the stock with a $5.00 price target.

Irhythm Technologies (IRTC)

Oppenheimer analyst Suraj Kalia maintained a Buy rating on Irhythm Technologies today and set a price target of $165.00. The company’s shares closed last Thursday at $110.88.

According to TipRanks.com, Kalia is a 4-star analyst with an average return of 6.2% and a 51.7% success rate. Kalia covers the Healthcare sector, focusing on stocks such as GE Healthcare Technologies Inc, Edwards Lifesciences, and Intuitive Surgical.

Currently, the analyst consensus on Irhythm Technologies is a Strong Buy with an average price target of $137.89, implying a 22.9% upside from current levels. In a report released yesterday, Wells Fargo also maintained a Buy rating on the stock with a $135.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on CI:

• CI Earnings: Cigna Rises on Strong Q1 Performance
• Cigna raises FY24 adjusted EPS view to $28.40 from $28.25, consensus $28.43
• Cigna reports Q1 adjusted EPS $6.47, consensus $6.22
• The Cigna Group Reports Strong First Quarter 2024 Results, Raises 2024 Outlook
• Notable companies reporting before tomorrow’s open